Collectively, these findings position GLP-1RAs as modulators of atherosclerotic disease beyond glycemic control, with integrated effects spanning systemic immunometabolism and plaque biology
Predictors of Therapy and Treatment Trends for Malignant Pleural Mesothelioma
Protein kinase D1 mediates NF-kappaB activation induced by cholecystokinin and cholinergic signaling in pancreatic acinar cells
The SURMOUNT clinical trial program, which supported FDA approval, included cardiovascular safety monitoring across more than 5,000 participants
Tirzepatide works by: Slowing gastric emptying , which prolongs the feeling of fullness after meals Reducing appetite through effects on brain centres that regulate hunger Improving insulin secretion in response to elevated blood glucose Decreasing glucagon secretion , which helps lower blood sugar levels Clinical trials have demonstrated that tirzepatide can lead to substantial weight losswith dose-dependent reductions of approximately 1520% of body weight over 72 weekswhen combined with lifestyle modifications
Supports a more refined and even-looking skin tone with Glutathione and Alpha Arbutin